ORL 2025
  • Welcome
  • Call for Abstracts
  • Speakers
    • Our Speakers
    • Information for Speakers
  • Programme
    • Mon 6 Oct
    • Tue 7 Oct
    • Wed 8 Oct
    • Thu 9 Oct
    • Social Programme
  • Registration
  • Sponsorship & Exhibition
    • Opportunities
    • Our Supporters
    • Information for Exhibitors
  • General Information
    • Venue
    • Accommodation
    • Helpful Info
    • Destination Hawke's Bay
    • Destination NZ
    • Our Environment
    • Health & Safety
  • Contact

Survival and Function following Primary Laryngectomy or Primary Chemoradiotherapy +/- Salvage laryngectomy in Advanced Laryngeal Cancer: 11-Year Retrospective Cohort Study​

Authors List:
McElroy, D., Cardiff University, School of Medicine, Cardiff, United Kingdom
Heyman, J., Smith, D., Exarchos S., Doddi NM., Department of Otolaryngology, Royal Glamorgan Hospital, Llantrisant, Cwm Taf Morgannwg Healthboard, United Kingdom
 
Introduction:
For advanced laryngeal cancer, larynx-preserving primary radiotherapy/chemoradiotherapy (P-CRT) may benefit from avoiding post-laryngectomy complications, and breathing, vocalisation or swallowing dysfunction which is paramount to patients' quality of life. However, risk of salvage total laryngectomy (STL) following non-surgical management failure is an important consideration where outcomes can be uncertain.
 
Aims:
This paper aims to elucidate locoregional oncological and post-treatment functional status following P-CRT +/- STL or primary total laryngectomy (PTL), hypothesising comparable survival outcomes.
 
Methods:
11-year retrospective analysis of 61 patients who underwent PTL (n=29) or P-CRT +/- STL (n=32) across Welsh regional health board. Outcomes were overall and disease-free survival, recurrence, post-treatment nutritional and vocal status, and post-laryngectomy complications. Survival estimates were analysed with Kaplan-Meier method.
 
Results:
Recurrence following P-CRT was higher but not statistically significant at 1- and 3-years compared to PTL (17.9 and 9.1% at 1 year; 45.5% and 20.0% at 3 years respectively), with a substantial proportion later receiving STL (31.3%). Overall survival rate and median disease-free survival were not significantly different between modalities at 1 and 3-years. Significantly greater late complications were associated with STL versus PTL (p=0.027), along with longer hospital stays and time to oral feeding (p<0.001). 81.8% and 85.2% of patients maintained oral nutritional intake following P-CRT and PTL, respectively. 86.4% of patients had a functional larynx following P-CRT, while 80.8% achieved vocal restoration following PTL.
 
Conclusion:
This retrospective analysis in a Welsh population shows comparable survival outcomes following both PTL and P-CRT +/- STL. Management of advanced laryngeal cancer involves a trade-off between the quality of life offered by preserving the structural and functional integrity of the larynx, with the higher chance of recurrence necessitating salvage surgery and associated morbidity.
​
For any queries please contact our Professional Conference Organiser (PCO):
Workz4U Conference Management Ltd
Po Box 90641, Victoria Street West, Auckland 1142, NZ
+64 21 325 133 ~ [email protected] ~ www.w4u.co.nz
Picture
Picture


ORL 2025 is the 78th Annual Scientific Meeting of the 
​The New Zealand Society of Otolaryngology,
Head & Neck Surgery

www.orl.org.nz
​

  • Welcome
  • Call for Abstracts
  • Speakers
    • Our Speakers
    • Information for Speakers
  • Programme
    • Mon 6 Oct
    • Tue 7 Oct
    • Wed 8 Oct
    • Thu 9 Oct
    • Social Programme
  • Registration
  • Sponsorship & Exhibition
    • Opportunities
    • Our Supporters
    • Information for Exhibitors
  • General Information
    • Venue
    • Accommodation
    • Helpful Info
    • Destination Hawke's Bay
    • Destination NZ
    • Our Environment
    • Health & Safety
  • Contact